皮肤黑色素瘤的皮肤镜特征与BRAF突变状态的关联:蓝白幕的意义
一项前瞻性横断面观察性描述性研究纳入93例皮肤黑色素瘤患者的93个病灶,分析皮肤镜特征与BRAF突变的关系。蓝白幕与BRAF突变显著相关(OR 4.3,95%CI 1.6-11.5,P=.003),BRAF突变者更年轻(OR 0.96,95%CI 0.93-0.99,P=.008),基于这两项变量预测BRAF突变状态的准确率为73%。
要点
- 皮肤镜下蓝白幕与皮肤黑色素瘤BRAF突变显著相关(OR 4.3,95%CI 1.6-11.5,P=.003)。
- BRAF突变型黑色素瘤患者较野生型显著年轻(OR 0.96,95%CI 0.93-0.99,P=.008)。
- 基于蓝白幕和年龄两变量预测BRAF突变状态的准确率为73%。
核心结论
- 皮肤镜下的蓝白幕与皮肤黑色素瘤的BRAF突变相关。
研究设计与样本
- 前瞻性、横断面、观察性、描述性研究,纳入93例皮肤黑色素瘤患者的93个病灶。
- BRAF突变状态通过cobas 4800 BRAF V600突变检测(罗氏分子系统,美国加利福尼亚州普莱森顿)和Sanger测序两种方法进行基因分析确定。
- 皮肤镜图像由2名独立盲法观察者分析,并收集临床病理资料。
主要发现
- 皮肤镜蓝白幕与BRAF突变显著相关(OR 4.3,95%CI 1.6-11.5,P=.003)。
- BRAF突变型黑色素瘤患者较野生型显著年轻(OR 0.96,95%CI 0.93-0.99,P=.008)。
- 基于蓝白幕和年龄两变量预测BRAF突变状态的准确率为73%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 组织学数据来自病理报告。
- 预测模型的准确性尚未在新数据集中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The genetic basis of melanoma affects its clinicopathologic characteristics and increasingly influences its management. B-Raf proto-oncogene, serine/threonine kinase gene (BRAF)-mutated melanoma may present with specific dermoscopic features. OBJECTIVES: To identify the dermoscopic features associated with BRAF mutation in cutaneous melanoma and to evaluate a model capable of predicting BRAF mutations on the basis of dermoscopic and clinicopathologic features that are easily accessible in normal clinical practice. METHODS: A prospective, cross-sectional, observational, and descriptive study was performed. A total of 93 cutaneous melanomas with dermoscopic images from 93 patients were included. BRAF mutational status was determined by genetic analysis using 2 methods: cobas 4800 BRAF V600 Mutation Test (Roche Molecular Systems, Pleasanton, CA) and Sanger sequencing. Clinicopathologic data were collected; dermoscopic images were analyzed by 2 independent blind observers. RESULTS: Blue-white veil in dermoscopy was significantly associated with BRAF mutations (odds ratio, 4.3; 95% confidence interval, 1.6-11.5; P = .003). Patients with BRAF-mutated melanomas were significantly younger than those with wild-type melanomas (odds ratio, 0.96; 95% confidence interval, 0.93-0.99; P = .008). On the basis of these 2 variables, it was possible to predict BRAF mutational status in melanoma with 73% accuracy. LIMITATIONS: Histologic data were obtained from pathology reports. The accuracy of the predictive model has not been tested with a new data set. CONCLUSIONS: Blue-white veil in dermoscopy is associated with BRAF mutations in cutaneous melanoma.
引用
- Armengot-Carbó M, Nagore E, García-Casado Z, et al. The association between dermoscopic features and BRAF mutational status in cutaneous melanoma: Significance of the blue-white veil. J Am Acad Dermatol. 2018. PMID: 29307636. doi:10.1016/j.jaad.2017.12.064
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。